Evidence map›Paper›PMID 35514687›Full record

ReviewRSC advances2019

Coated silver nanoparticles: synthesis, cytotoxicity, and optical properties.

Heba Mohamed Fahmy, Ayaat Mahmoud Mosleh, Aya Abd Elghany, Engy Shams-Eldin, Esraa Samy Abu Serea, Somaia Ashour Ali, Ahmed Esmail Shalan

Abstract readReview
In one paragraph

Review in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Emerging Resistance and Virulence Patterns inAntibiotics (Basel, Switzerland) · 2025
    Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Heba Mohamed FahmyBiophysics Department, Faculty of Science, Cairo University 12613 Egypt hfahmy@sci.cu.edu.eg.
Ayaat Mahmoud MoslehBiophysics Department, Faculty of Science, Cairo University 12613 Egypt hfahmy@sci.cu.edu.eg.
Aya Abd ElghanyBiochemistry Department, Faculty of Science, Cairo University 12613 Egypt.
Engy Shams-EldinFood Technology Research Institute, Agriculture Research Center Giza Egypt.ORCID https://orcid.org/0000-0003-2701-1159
Esraa Samy Abu SereaChemistry & Biochemistry Department, Faculty of Science, Cairo University 12613 Egypt.
Somaia Ashour AliBiophysics Department, Faculty of Science, Cairo University 12613 Egypt hfahmy@sci.cu.edu.eg.
Ahmed Esmail ShalanCentral Metallurgical Research and Development Institute P. O. Box 87 Helwan 11422 Cairo Egypt a.shalan133@gmail.com +202-25010639 +202-25010640-43.ORCID https://orcid.org/0000-0002-3424-1609

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coated silver nanoparticles (AgNPs) have recently become a topic of interest due to the fact that they have several applications such as in electronic, antimicrobial, industrial, optical, and medical fields as biosensors and drug delivery systems. However, the use of AgNPs in medical fields remains somewhat limited due to their probable cytotoxic effect. Researchers have succeeded in reducing the toxicity of silver particles by coating them with different substances. Generally, the coating of AgNPs leads to change in their properties depending on the type of the coating material as well as the layer thickness. This review covers the state-of-the-art technologies behind (a) the synthesis of coated AgNPs including coating methods and coating materials, (b) the cytotoxicity of coated AgNPs and (c) the optical properties of coated AgNPs.

Identifiers

PMID35514687
PMCPMC9065456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.